Series B Shares. A total of 30,308,284 authorized series B preferred shares of par value US$0.00025 per share (the “Series B Shares), of which 30,308,284 shares are in issue and outstanding.
Series B Shares. Series B Shares" --------------- shall mean the 71,376,124 Class II shares of Series B Common Stock, no par value, of G-Modelo authorized for issuance upon conversion of shares of G-Modelo capital stock as provided in the Amended G-Modelo By-laws.
Series B Shares. Issuer: Banro Corporation (“Banro”). Issue Size: 1,200,000 preferred shares, series B (the “Series B Shares”). One Series B Share will be issued with each Barbados Preferred Share.
Series B Shares. The REIT Merger shall have no effect on the Company’s outstanding Series B Shares and, at and after the REIT Effective Time, the Series B Shares shall be the outstanding Series B Shares of the Surviving Entity.
Series B Shares. The Series B Shares shall have the powers, rights, preferences and privileges set forth in the Series B Certificate of Designations.
Series B Shares. At or prior to the Initial Closing, the Company shall have filed the Certificate of Designation with the Secretary of State of Delaware.
Series B Shares. A total of 39,485,114 authorized Series B Shares, none of which are issued and outstanding. The rights and preferences of the Preferred Shares are set forth in the Second Amended and Restated Memorandum and Articles of Association of the Company attached hereto as Exhibit B (the “Restated Articles”), which shall be adopted and filed with the Registrar of Companies of the Cayman Islands and remain the Constitutional Documents (as defined below) of the Company in effect upon the Closing. Each of the Preferred Shares is convertible into Ordinary Shares on an initial ratio of 1:1, and no issuances have been made prior to the date hereof, or will be made prior to the Closing, which has had, or should have had, the effect of modifying the conversion ratio of any Preferred Shares.
Series B Shares. Each Series B Share that is not a Treasury Share or a Dissenting Share will be cancelled and automatically converted into the right to receive, without interest and subject to any applicable withholding obligations:
Series B Shares. A total of 39,485,114 authorized Series B Shares, all of which are issued and outstanding.
Series B Shares. The Series B Shares shall be issued as “preferred” Series B Shares. The Series B Shares will grant to CBAI and DRK-BSD preferential rights above all other shareholders of the Company. The Series B Shares accorded to CBAI and DRK-BSD shall include the rights as determined in that certain Shareholder Agreement among the Existing Shareholders, CBAI and the Company which shall be signed and notarized on the same date as this Agreement as set forth in Section 5.2 and Annex 5.2 (hereafter “Shareholder Agreement”). Said rights included, in particular, the right to preferred payment up to the full amount of the following Investment Amounts:
